Liminatus Pharma, Inc.
Liminatus Pharma, Inc. scores highest on Anchor (52) and lowest on Nitro (3). Its PosiPenta is 13.85 out of 100, clearly weaker than most similar companies.
On the Penta Grid this week, Liminatus Pharma, Inc. is Grid #835 of 837 in the Healthcare sector in United States, and Grid #3,991 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Liminatus Pharma, Inc. | 13.85 | 6 | 4 | 3 | 5 | 52 |
| cbdMD, Inc. | 44.95 | 92 | 40 | 16 | 46 | 31 |
| Jaguar Health, Inc. | 22.74 | 39 | 40 | 3 | 7 | 25 |
| Dermata Therapeutics, Inc. | 38.00 | 37 | 23 | 25 | 52 | 53 |
| bioAffinity Technologies, Inc. | 24.07 | 36 | 40 | 10 | 17 | 17 |
| Azitra, Inc. | 31.86 | 44 | 38 | 15 | 35 | 27 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.13 |
| P/B ratio | 13.58 |
EEarnings
| Trailing EPS | ₹-2225.80 |
| Forward EPS | — |
NNitro
| Price | 287.93 |
| 52-week high | 13402.17 |
| 52-week low | 285.09 |
| Fall from 52-week high | 97.9% |
TTorque
| Return on equity (ROE) | — |
| Debt-to-equity | 4.80 |
AAnchor
| Beta (price swings) | 0.75 |
| Market cap | ₹38 Cr |
| Insider holding | 27.18% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Liminatus Pharma, Inc.'s PosiPenta score?
Liminatus Pharma, Inc.'s PosiPenta is 13.85 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Liminatus Pharma, Inc. stand on the Penta Grid?
On the Penta Grid this week, Liminatus Pharma, Inc. is Grid #835 of 837 in the Healthcare sector in United States, and Grid #3,991 of 4,000 in United States.
Which PosiPenta pillar is strongest for Liminatus Pharma, Inc.?
Anchor (stability and dividends), with a score of 52 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Liminatus Pharma, Inc.?
Nitro (momentum), with a score of 3 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.